Literature DB >> 35144238

A social media intervention for cannabis use among emerging adults: Randomized controlled trial.

Erin E Bonar1, Jason E Goldstick2, Lyndsay Chapman3, José A Bauermeister4, Sean D Young5, Jenna McAfee6, Maureen A Walton7.   

Abstract

PURPOSE: Cannabis use is increasing among emerging adults (ages 18-25), necessitating the need for prevention interventions. Using a novel platform - social media - we developed an 8-week motivational interviewing and cognitive-behavioral intervention targeting cannabis use among emerging adults. Herein, we report on the feasibility and acceptability of the intervention in a pilot trial. PROCEDURES: For NCT04187989 we recruited N = 149 emerging adults who used cannabis (at least 3 times/week for the past month) using social media advertising. Their mean age was 21.0 years (SD = 2.2); 55.7% were female. Most were White (70.5%; 20.1% Black/African American, 9.4% Other races), with 20.1% identifying as Hispanic/Latinx. Participants were randomized to the 8-week intervention or an 8-week attention-placebo control condition, both delivered in secret Facebook groups by electronic health coaches (e-coaches). Follow-up assessments occurred at 3- and 6-months.
RESULTS: The intervention was well-received and follow-up rates were high; fidelity was good. Intervention participants rated e-coaches significantly higher in terms of helpfulness, warmth, etc., compared to control participants. Intervention participants were more likely to engage with and recommend the group. In terms of percentage reductions in cannabis outcomes, the intervention group evidenced absolute reductions over time in several measures of cannabis consumption across modalities. In an adjusted model, reductions in vaping days in the intervention group, relative to attention-control, reached statistical significance (p = .020, D =.40).
CONCLUSIONS: This social media intervention for emerging adults' cannabis use was feasible and acceptable in the target population warranting future testing in a fully powered trial.
Copyright © 2022 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cannabis; Emerging adults; Motivational interviewing; Social media

Mesh:

Year:  2022        PMID: 35144238      PMCID: PMC9549699          DOI: 10.1016/j.drugalcdep.2022.109345

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.852


  66 in total

1.  The 2-item Generalized Anxiety Disorder scale had high sensitivity and specificity for detecting GAD in primary care.

Authors:  Petros Skapinakis
Journal:  Evid Based Med       Date:  2007-10

Review 2.  The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda.

Authors:  Mallory J E Loflin; Brian D Kiluk; Marilyn A Huestis; Will M Aklin; Alan J Budney; Kathleen M Carroll; Deepak Cyril D'Souza; Robert H Dworkin; Kevin M Gray; Deborah S Hasin; Dustin C Lee; Bernard Le Foll; Frances R Levin; Joshua A Lile; Barbara J Mason; Aimee L McRae-Clark; Ivan Montoya; Erica N Peters; Tatiana Ramey; Dennis C Turk; Ryan Vandrey; Roger D Weiss; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2020-04-26       Impact factor: 4.492

3.  Association of Cannabis Use With All-Cause and Cause-Specific Mortality Among Younger- and Middle-Aged U.S. Adults.

Authors:  Yangbo Sun; Buyun Liu; Robert B Wallace; Wei Bao
Journal:  Am J Prev Med       Date:  2020-11-18       Impact factor: 5.043

4.  Assessing the public health impacts of legalizing recreational cannabis use: the US experience.

Authors:  Wayne Hall; Michael Lynskey
Journal:  World Psychiatry       Date:  2020-06       Impact factor: 49.548

Review 5.  Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis.

Authors:  Faye Plummer; Laura Manea; Dominic Trepel; Dean McMillan
Journal:  Gen Hosp Psychiatry       Date:  2015-11-18       Impact factor: 3.238

6.  Variation in cannabis potency and prices in a newly legal market: evidence from 30 million cannabis sales in Washington state.

Authors:  Rosanna Smart; Jonathan P Caulkins; Beau Kilmer; Steven Davenport; Greg Midgette
Journal:  Addiction       Date:  2017-07-04       Impact factor: 6.526

Review 7.  Adverse health effects of marijuana use.

Authors:  Nora D Volkow; Ruben D Baler; Wilson M Compton; Susan R B Weiss
Journal:  N Engl J Med       Date:  2014-06-05       Impact factor: 91.245

8.  Project reduce: reducing alcohol and marijuana misuse: effects of a brief intervention in the emergency department.

Authors:  Robert Woolard; Janette Baird; Richard Longabaugh; Ted Nirenberg; Christina S Lee; Michael J Mello; Bruce Becker
Journal:  Addict Behav       Date:  2012-09-23       Impact factor: 3.913

Review 9.  Changes in delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta-analysis.

Authors:  Tom P Freeman; Sam Craft; Jack Wilson; Stephan Stylianou; Mahmoud ElSohly; Marta Di Forti; Michael T Lynskey
Journal:  Addiction       Date:  2020-11-07       Impact factor: 6.526

10.  Feasibility and Quit Rates of the Tobacco Status Project: A Facebook Smoking Cessation Intervention for Young Adults.

Authors:  Danielle E Ramo; Johannes Thrul; Kathryn Chavez; Kevin L Delucchi; Judith J Prochaska
Journal:  J Med Internet Res       Date:  2015-12-31       Impact factor: 5.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.